Aspen Pharmacare Holdings Limited

JSE:APN Stok Raporu

Piyasa değeri: R79.3b

Aspen Pharmacare Holdings Yönetim

Yönetim kriter kontrolleri 4/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Stephen Saad

İcra Kurulu Başkanı

R27.3m

Toplam tazminat

CEO maaş yüzdesi35.2%
CEO görev süresi25yrs
CEO sahipliği11.8%
Yönetim ortalama görev süresi7.8yrs
Yönetim Kurulu ortalama görev süresi5.8yrs

Son yönetim güncellemeleri

We Think Shareholders May Want To Consider A Review Of Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Package

Nov 29
We Think Shareholders May Want To Consider A Review Of Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Package

Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Recent updates

We Think Shareholders May Want To Consider A Review Of Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Package

Nov 29
We Think Shareholders May Want To Consider A Review Of Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Package

Aspen Pharmacare Holdings Limited (JSE:APN) Not Lagging Market On Growth Or Pricing

Nov 09
Aspen Pharmacare Holdings Limited (JSE:APN) Not Lagging Market On Growth Or Pricing

Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings

Oct 10
Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings

Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden

Oct 01
Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden

Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59

Sep 10
Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59

We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

May 08
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Mar 05
Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Dec 22
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Mar 31
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

Jan 11
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

Oct 22
These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Oct 06
We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Sep 21
Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Sep 08
Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Sep 07
Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Jun 15
Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

Apr 02
Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

Mar 16
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Mar 02
An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Dec 23
Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

Dec 02
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

Oct 11
We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Sep 30
After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

Sep 30
Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

CEO Tazminat Analizi

Stephen Saad'un ücretlendirmesi Aspen Pharmacare Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024R27mR10m

R4b

Mar 31 2024n/an/a

R5b

Dec 31 2023n/an/a

R5b

Sep 30 2023n/an/a

R5b

Jun 30 2023R24mR9m

R5b

Mar 31 2023n/an/a

R6b

Dec 31 2022n/an/a

R6b

Sep 30 2022n/an/a

R6b

Jun 30 2022R23mR9m

R6b

Mar 31 2022n/an/a

R6b

Dec 31 2021n/an/a

R6b

Sep 30 2021n/an/a

R5b

Jun 30 2021R24mR8m

R5b

Mar 31 2021n/an/a

R4b

Dec 31 2020n/an/a

R4b

Sep 30 2020n/an/a

R4b

Jun 30 2020R23mR8m

R3b

Mar 31 2020n/an/a

R3b

Dec 31 2019n/an/a

R870m

Sep 30 2019n/an/a

R1b

Jun 30 2019R14mR8m

R2b

Mar 31 2019n/an/a

R3b

Dec 31 2018n/an/a

R5b

Sep 30 2018n/an/a

R5b

Jun 30 2018R17mR7m

R6b

Tazminat ve Piyasa: Stephen 'ın toplam tazminatı ($USD 1.46M ) ZA pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 1.46M ).

Tazminat ve Kazançlar: Stephen 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Stephen Saad (60 yo)

25yrs

Görev süresi

R27,303,000

Tazminat

Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Stephen Saad
Group CEO & Executive Director25yrsR27.30m11.82%
ZAR 9.4b
Sean Capazorio
Group CFO & Executive Director26yrsR16.66mVeri yok
Lorraine Hill
Group Chief Operations Officer11.2yrsR17.18mVeri yok
Michael Attridge
Group Chief Advisor3yrsR11.14m4.32%
ZAR 3.4b
Reginald Haman
Group Chief Corporate Officer & Executive Director1.1yrsR13.79mVeri yok
Zizipho Mmango
Group Chief Strategic Development Officer4.7yrsR12.81mVeri yok
Sibongakonke Nkosi
Investor Relations Managerno dataVeri yokVeri yok
Raeesa Khan
Group Company Secretary & Chief of Staff1yrVeri yokVeri yok
Trevor Ziman
Regional Chief Executive Officer of Asia Pacific11yrsVeri yokVeri yok
Samer Kassem
Chief Executive Officer of Aspen Global Incorporated7.8yrsVeri yokVeri yok
Luresha Chetty
Corporate Affairs & Investor Relations Executiveno dataVeri yokVeri yok

7.8yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim: APN 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.8 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Stephen Saad
Group CEO & Executive Director26yrsR27.30m11.82%
ZAR 9.4b
Sean Capazorio
Group CFO & Executive Director3yrsR16.66mVeri yok
Reginald Haman
Group Chief Corporate Officer & Executive Directorless than a yearR13.79mVeri yok
Ben Kruger
Lead Independent Non-Executive Director5.8yrsR1.27mVeri yok
Christopher Mortimer
Non-Executive Director26yrsR551.00kVeri yok
Kuseni Dlamini
Independent Non-Executive Chairman12.8yrsR1.49mVeri yok
Yvonne Muthien
Independent Non-Executive Director3.1yrsR1.08mVeri yok
David Redfern
Non-Executive Director9.9yrsR427.00kVeri yok
Linda de Beer
Independent Non-Executive Director6.5yrsR1.14mVeri yok
Neo Dongwana
Independent Non-Executive Directorless than a yearR183.00kVeri yok
Themba Mkhwanazi
Independent Non-Executive Director5.8yrsR432.00kVeri yok

5.8yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: APN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.8 yıldır).


Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2025/01/31 11:45
Gün Sonu Hisse Fiyatı2025/01/31 00:00
Kazançlar2024/06/30
Yıllık Kazançlar2024/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Aspen Pharmacare Holdings Limited 18 Bu analistlerden 5, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Andre BekkerArqaam Capital Research Offshore S.A.L.
Boitshepo SeruweAvior Capital Markets
Simon MatherBarclays